Machado-Joseph Disease, A Case Report of Treatment Based on Phototherapy

Authors

Keywords:

Palliative care, phototherapy, spinocerebellar ataxia type 3

Abstract

Machado-Joseph disease (MJD) is a rare autosomal dominant disease caused by a mutation in exon 10 of the ATXN3 gene resulting from a cytosineadenine-guanine trinucleotide repeat. A case of a 48-year-old man with MJD is reported. His father, two paternal aunts, and his older sister all died because of this disease, and his younger brother had the same disease. Due to the absence of therapeutic options, phototherapy sessions were offered as an alternative between 425 and 650 nm 1.33 Joules/cm2, 30 cm above the chest. After three months of phototherapy sessions, the following items showed a decrease in their scores: physical functioning, role limitations due to physical health, role limitations due to emotional problems, energy/fatigue, emotional well-being, social functioning, and general health. The only variable that remained unchanged was pain. He discontinued treatment, attributed the deterioration to phototherapy. A year later, as the disease progressed, he decided to resume the same scheme, and the following trends were observed: a) Improvement in role limitations due to physical health, emotional well-being, social functioning, and general health; b) No changes in role limitations due to emotional problems and pain and c) deterioration in energy/fatigue.

References

1. Ye ZX, Xu HL, Chen NP, Chen XY, Li MC, et al. Disease progression and multiparametric imaging characteristics of spinocerebellar ataxia type 3 with spastic paraplegia. Neurol Genet. 2024;10:200162.

2. Paulson H. Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol. 2012;103:437-49.

3. Moraes DBV, Coradine TLC, Silva EVL, Sobreira-Neto MA, Marques W, et al. Genetic epidemiology and clinical characteristics of patients with

spinocerebellar ataxias in an unexplored Brazilian State, using strategies for resource-limited settings. Cerebellum. 2023;23:609-19.

4. Peng Y, Peng L, Chen Z, Peng H, Wang P, et al. The natural history of spinocerebellar ataxia type 3 in mainland china: a 2-year cohort study. Front Aging Neurosci. 2022;14:917126.

5. Coutinho P, Sequeiros J. [Clinical, genetic and pathological aspects of Machado-Joseph disease]. J Genet Hum. 1981;29:203-9.

6. Fowler HL. Machado-Joseph-Azorean disease: a ten-year study. Arch Neurol. 1984;41:921-5.

7. Stahl F, Evert BO, Han X, Breuer P, Wüllner U. Spinocerebellar ataxia type 3 pathophysiology-implications for translational research and clinical studies. Int J Mol Sci. 2024;25:3984.

8. Chen X, Tang TS, Tu H, Nelson O, Pook M, et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3. J Neurosci. 2008;28:12713-24.

9. Oyanagi K, Shimizu H, Yamada M, Kakita A. The neostriatum in polyglutamine diseases: preferential decreases in large neurons in dentatorubralpallidoluysian atrophy and Machado‐Joseph disease and in small neurons in Huntington disease. Neuropathology. 2022;42:274-81.

10. Weishäupl D, Schneider J, Peixoto Pinheiro B, Ruess C, Dold SM, et al. Physiological and pathophysiological characteristics of ataxin-3 isoforms. J Biol Chem. 2019;294:644-61.

11. Ding L, Gu Z, Chen H, Wang P, Song Y, et al. Phototherapy for age-related brain diseases: challenges, successes and future. Ageing Res Rev. 2024;94:102183.

12. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83.

13. Leal Espinosa F. Nacen nuevas esperanzas para las enfermedades incurables. Tomo III. Ciudad de México: Directorios Industriales; 1998. 132 p. Nacen nuevas esperanzas para las enfermedades incurables - NLM Catalog - NCBI.

14. da Silva Neto Trajano LA, Trajano ETL, da Silva Sergio LP, Teixeira AF, Mencalha AL, et al. Photobiomodulation effects on mRNA levels from

genomic and chromosome stabilization genes in injured muscle. Lasers Med Sci. 2018;33:1513-9.

15. da Silva Carvalho G, Saute JA, Haas CB, Torrez VR, Brochier AW, et al. Cytokines in Machado Joseph disease/spinocerebellar ataxia 3. Cerebellum. 2016;15:518-25.

Downloads

Published

20.11.2024

How to Cite

Mendieta Zerón, H., Emmanuel González Mendoza, D., Lagos Robles, P., & Deyanira Rodriguez Piña, M. (2024). Machado-Joseph Disease, A Case Report of Treatment Based on Phototherapy. Caucasian Medical Journal, 2(3), 36–39. Retrieved from https://caucasianmedj.com/index.php/pub/article/view/44

Issue

Section

Case Report

Similar Articles

You may also start an advanced similarity search for this article.